In keeping with the Otsuka group’s CSR Vision, Taiho Pharmaceutical takes various initiatives, internally and externally, drawing on the knowledge and experience it has gained as a company closely connected with human life.
Taiho Pharmaceutical is one of Japan’s foremost creators of anticancer agents, with 50 years of experience in chemotherapies. Taiho Pharmaceutical pioneered oral anticancer formulations before they became common worldwide. In 1974, the company introduced the oral anticancer agent Futraful, and has since brought to market UFT (in 1984), TS-1 (in 1999), and LONSURF (in 2014). The company strives to meet patients’ needs in the area of oncology, including new formulations (UFT in capsules and enteric granules; and TS-1 in capsules, granules, and orally disintegrating tablets) and development of UZEL (in 2003) with the aim of strengthening the efficacy of UFT in treating colorectal cancer. These oral formulations are recommended in medical guidelines for a number of different cancers in Japan.Recommended under treatment guidelines in Europe and North America, LONSURF, a treatment for metastatic colorectal cancer, and, in U.S., a treatment for metastatic gastric cancer, is expected to help improve the treatment of cancer worldwide. The company also continues its global clinical development of new products. While there has been enormous recent progress in cancer treatment, significant unmet medical needs remain. Following its development in Japan, in 2015 Taiho Pharmaceutical launched Yondelis, a treatment for soft tissue sarcoma that is recommended in European and North American medical guidelines. The company also is committed to developing treatments for rare cancers in cases where unmet medical needs are deep. With the patient’s perspective in mind, the Otsuka group is committed to research and development on new anticancer drugs that will be integral in future cancer treatments and that will help with supportive care, such as antiemetic agents and drugs to alleviate cancer pain.
Taiho Pharmaceutical has established an Environmental Policy based on the Otsuka Group Environmental Policy and is striving to achieve its environmental targets.
Taiho Pharmaceutical emphasizes connections with society and individual communities through various activities.
Taiho Pharmaceutical conducted a commemorative event in the form of CSR initiatives with employee participation to mark its 55th anniversary in 2017. During the event, Taiho Pharmaceutical sold within the company 55th-anniversary limited-edition packages of Tiovita Drink. The company will donate a total of 55 million yen—the full proceeds from the sale of those packages plus a matching gift from the company—every year, over the five years from 2017 to 2021, to a total of 15 organizations involved with cancer and health. A second donation was made in 2018. The amount given to the 15 organizations will reflect the wishes of the employees who made the purchases. The donations are intended to support each organization’s future activities.
Taiho Pharmaceutical supports the Pink Ribbon Campaign, a worldwide effort to raise awareness of breast cancer. In its campaign activities, Taiho Pharmaceutical disseminates accurate information about breast cancer and promotes early screening.
Taiho Pharmaceutical will continue providing information both in and outside the company so that society as a whole will be more aware of breast cancer. Taiho wants you and those you love to keep smiling into the future.
Since fiscal 2010, the Tokushima Plant has signed annual partnership agreements for the Cooperative Forestry Project with Tokushima Prefecture and the Tokushima Forestry Promotion Organization. Through these agreements, Taiho Pharmaceutical sponsors forest promotion projects within the prefecture. The activities, such as forest maintenance and conservation through thinning, etc., have increased CO2 absorption by these forests, which in turn helps to address global warming. Taiho Pharmaceutical will continue to support the Cooperative Forestry Project, not just through donations, but also through thinning and tree planting carried out by employees and their families. Starting in 2019, Taiho Pharmaceutical will sponsor a forest promotion project at the upper reaches of the Anabuki River in western Tokushima Prefecture together with other Otsuka Group companies in the prefecture.
Recognizing the great value of its human resources, Taiho Pharmaceutical promotes diversity and is working hard to ensure that every employee is able to work with vitality.
Taiho Pharmaceutical was recognized as a White 500 company* in 2019 for its wide range of initiatives related to employee health. White 500 is a group of companies with outstanding health and productivity management jointly selected by the Ministry of Economy, Trade and Industry (METI) and Nippon Kenko Kaigi. This is the second year in a row that Taiho Pharmaceutical was recognized.
In 2017, Taiho Pharmaceutical released its Health Pledge, which vows to “further enhance workplace environments across our entire organization so that employees can work with even more freedom and energy. We will do this by supporting the physical and mental health of all employees.” The pledge is intended to uphold the company’s corporate philosophy—“We strive to improve human health and contribute to a society enriched by smiles.”
*The Certified Health and Productivity Management Organization Recognition Program recognizes both large companies and small- and medium-sized enterprises for outstanding efforts in health and productivity management.
Taiho Pharmaceutical has been working to improve the work-life balance of all employees in various ways, including a work-at-home scheme, special days to promote the use of paid leave, and days when employees are encouraged to leave work on time. The company’s Personal Career Counseling Office, staffed with industrial counselors and career consultants, endeavors to provide support that facilitates personal growth.
To support the balancing of work and child-rearing, Taiho Pharmaceutical has put in place systems that go beyond statutory requirements and conducts interviews with employees during pregnancy, before maternity leave, and when employees return to work. Taiho Pharmaceutical established Sukusuku Nursery, an on-site daycare in the Tsukuba area (Ibaraki Prefecture). The nursery is able to offer temporary childcare, care for a sick child, and extended-hours childcare, etc. This enables female employees to advance their careers and male employees to be more actively involved in raising their children. Going forward, Taiho Pharmaceutical will keep aiming to create better workplaces for all employees, enabling each and every employee to participate actively by offering diverse work styles that fit each stage of life.